Value in Healthcare Initiative: Summary and Key Recommendations.

Circulation. Cardiovascular Quality and Outcomes
Karen Joynt MaddoxMadeleine Konig

Abstract

In spring 2018, the American Heart Association convened the Value in Healthcare Summit to begin an important conversation about the challenges patients with cardiovascular disease face in accessing and deriving quality and value from the healthcare system. Following the summit and recognizing the collective momentum it created, the American Heart Association, in collaboration with the Robert J. Margolis Center for Health Policy at Duke University, launched the Value in Healthcare Initiative-Transforming Cardiovascular Care. Four areas of focus were identified, and learning collaboratives were established and proceeded to conduct concrete, actionable problem solving in 4 high-impact areas in cardiovascular care: Value-Based Models, Partnering with Regulators, Predict and Prevent, and Prior Authorization. The deliverables from these groups are being disseminated in 4 stand-alone articles, and their publication will initiate further work to test and evaluate each of these promising areas of reform. This article provides an overview of the initiative's findings and highlights key cross-cutting themes for consideration as the initiative moves forward.

References

Aug 4, 2010·Pharmacoepidemiology and Drug Safety·Dima M QatoG Caleb Alexander
Apr 1, 1988·American Journal of Health Promotion : AJHP
May 18, 2013·Circulation. Cardiovascular Quality and Outcomes·Feng QianDeepak L Bhatt
Sep 3, 2013·The New England Journal of Medicine·Michael S Lauer, Ralph B D'Agostino
Mar 7, 2014·Journal of Community Hospital Internal Medicine Perspectives·Robert D ChowMihriye Mete
Aug 5, 2015·Circulation·Edward P HavranekUNKNOWN American Heart Association Council on Quality of Care and Outcomes Research, Council on Epidemiology and Prevention, Council
Sep 18, 2015·BMC Psychology·Mark S BauerAmy M Kilbourne
Feb 20, 2016·Emergency Medicine Journal : EMJ·Margaret A HandleyAdithya Cattamanchi
Jul 11, 2016·JACC. Heart Failure·Mitchell A PsotkaJohn R Teerlink
Nov 9, 2016·Journal of Medical Internet Research·Jane Topolovec-Vranic, Karthik Natarajan
Jan 21, 2017·Circulation Research·George A MensahDavid Gordon
Sep 1, 2017·The Journal of Clinical Hypertension·Keith C FerdinandFortunato Fred Senatore
Sep 8, 2017·MMWR. Morbidity and Mortality Weekly Report·Quanhe YangMary G George
Feb 2, 2018·Journal of the American College of Cardiology·Christopher M O'ConnorRobert M Califf
Apr 6, 2018·Research Involvement and Engagement·Meghana ChalasaniTheresa Mullin
May 5, 2018·Journal of the American College of Cardiology·Pamela E ScottJanet Woodcock
Aug 7, 2018·Health Affairs·Jonathan D CampbellAndrew H Briggs
Oct 8, 2019·JAMA Internal Medicine·Navindra PersaudUNKNOWN Carefully Selected and Easily Accessible at No Charge Medicines (CLEAN Meds) Study Team
Oct 8, 2019·JAMA : the Journal of the American Medical Association·William H ShrankNatasha Parekh
May 13, 2020·Circulation. Cardiovascular Quality and Outcomes·Karen Joynt MaddoxUNKNOWN and the American Heart Association Value-Based Models Learning Collaborative
May 13, 2020·Circulation. Cardiovascular Quality and Outcomes·Kristine HuangKaren E Joynt Maddox
Jul 21, 2020·Circulation. Cardiovascular Quality and Outcomes·Mitchell A PsotkaUNKNOWN American Heart Association Prior Authorization Learning Collaborative*
Jul 21, 2020·Circulation. Cardiovascular Quality and Outcomes·John J WarnerUNKNOWN American Heart Association Partnering with Regulators Learning Collaborative*

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Circulation. Cardiovascular Quality and Outcomes
Mark B McClellanKaren Joynt Maddox
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
Benjamin F ByrdSarah Woodruff
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare
Mark W ScerboJohn Sokolowski
© 2021 Meta ULC. All rights reserved